Published in J Virol on February 01, 1998
Mutation rates among RNA viruses. Proc Natl Acad Sci U S A (1999) 6.37
Viral mutation rates. J Virol (2010) 3.87
Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am J Respir Cell Mol Biol (2005) 1.64
Role of interfacial amino acid residues in assembly, stability, and conformation of a spherical virus capsid. Proc Natl Acad Sci U S A (2004) 1.36
Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway. Am J Respir Cell Mol Biol (2008) 1.29
Biological characteristics and propagation of human rhinovirus-C in differentiated sinus epithelial cells. Virology (2012) 1.20
Human rhinovirus type 16: mutant V1210A requires capsid-binding drug for assembly of pentamers to form virions during morphogenesis. J Virol (2003) 1.07
Pocket factors are unlikely to play a major role in the life cycle of human rhinovirus. J Virol (2007) 0.94
Negative control of TLR3 signaling by TICAM1 down-regulation. Am J Respir Cell Mol Biol (2011) 0.87
Mechanisms of viral mutation. Cell Mol Life Sci (2016) 0.85
Characterization of Poliovirus Neutralization Escape Mutants of Single-Domain Antibody Fragments (VHHs). Antimicrob Agents Chemother (2015) 0.79
Mutations in VP1 and 3A proteins improve binding and replication of rhinovirus C15 in HeLa-E8 cells. Virology (2016) 0.79
Production, purification, and capsid stability of rhinovirus C types. J Virol Methods (2015) 0.79
Modulation of airway epithelial antiviral immunity by fungal exposure. Am J Respir Cell Mol Biol (2014) 0.77
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52
Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (1985) 12.90
Three-dimensional structure of poliovirus at 2.9 A resolution. Science (1985) 11.47
The major human rhinovirus receptor is ICAM-1. Cell (1989) 7.81
A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell (1989) 6.37
On the structure of rhinovirus 1A. Virology (1971) 4.57
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science (1986) 4.40
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J (1989) 4.12
Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J Virol (1985) 3.44
Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc Natl Acad Sci U S A (1988) 3.29
Nucleotide sequence coding for the "signal peptide" and N terminus of the hemagglutinin from an asian (H2N2) strain of influenza virus. Virology (1979) 3.01
Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. Antimicrob Agents Chemother (1986) 2.70
Crystal structure of human rhinovirus serotype 1A (HRV1A). J Mol Biol (1989) 2.49
Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J Virol (1993) 2.39
Host range mutants of human rhinovirus in which nonstructural proteins are altered. J Virol (1983) 2.19
Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J (1994) 2.03
Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest (1989) 1.97
Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J Virol (1989) 1.92
The structure of human rhinovirus 16. Structure (1993) 1.83
The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle. Structure (1997) 1.82
Structure of a human rhinovirus-bivalently bound antibody complex: implications for viral neutralization and antibody flexibility. Proc Natl Acad Sci U S A (1993) 1.79
Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group. Virus Genes (1995) 1.74
Inhibition of poliovirus uncoating by disoxaril (WIN 51711). Virology (1987) 1.73
WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present. J Virol (1993) 1.66
Transmission of experimental rhinovirus colds in volunteer married couples. J Infect Dis (1976) 1.66
Early events in poliovirus infection: virus-receptor interactions. Proc Natl Acad Sci U S A (1996) 1.58
Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology (1989) 1.53
Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions. J Virol (1994) 1.48
Selective inhibiton of uncoating of echovirus 12 by rhodanine. A study on early virus-cell interactions. Virology (1977) 1.39
Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother (1989) 1.33
An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. J Virol (1991) 1.31
WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14. J Virol (1993) 1.30
A model for obtaining predictable natural transmission of rhinoviruses in human volunteers. J Infect Dis (1984) 1.22
Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis (1991) 1.08
Effects of experimental rhinovirus 16 infection on airways and leukocyte function in normal subjects. J Allergy Clin Immunol (1978) 0.95
Reduced granulocyte response to isoproterenol, histamine, and prostaglandin E1 after in vitro incubation with Rhinovirus 16. Am Rev Respir Dis (1980) 0.83
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med (1998) 14.40
Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (1985) 12.90
Observations on molecular weight determinations on polyacrylamide gel. J Biol Chem (1969) 7.60
Systematic nomenclature of picornavirus proteins. J Virol (1984) 5.26
On the structure of rhinovirus 1A. Virology (1971) 4.57
Acetaminophen toxicity in an urban county hospital. N Engl J Med (1997) 4.26
Virus-specific proteins synthesized in encephalomyocarditis virus-infected HeLa cells. Proc Natl Acad Sci U S A (1971) 4.20
Protease required for processing picornaviral coat protein resides in the viral replicase gene. J Virol (1979) 3.70
Translation of encephalomyocarditis virus RNA in reticulocyte lysates: kinetic analysis of the formation of virion proteins and a protein required for processing. J Virol (1979) 3.64
Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol (1986) 3.59
Identification of the human c-myc protein nuclear translocation signal. Mol Cell Biol (1988) 3.30
Properties of a ribonucleoprotein particle isolated from Nonidet P-40-treated Rous sarcoma virus. J Virol (1972) 3.25
Evidence for intramolecular self-cleavage of picornaviral replicase precursors. J Virol (1982) 3.03
Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J Biol Chem (1989) 2.89
Max: functional domains and interaction with c-Myc. Genes Dev (1992) 2.88
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol (1981) 2.81
Structural studies of avian myeloblastosis virus: comparison of polypeptides in virion and core component by dodecyl sulfate-polyacrylamide gel electrophoresis. J Virol (1974) 2.79
Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg (1999) 2.79
Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein. Nature (1989) 2.70
c-myc gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGF. Cell (1985) 2.69
Autonomous replication and expression of RNA 1 from black beetle virus. J Virol (1983) 2.68
Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J Virol (1988) 2.67
Synthesis of Black Beetle Virus Proteins in Cultured Drosophila Cells: Differential Expression of RNAs 1 and 2. J Virol (1981) 2.65
Assembly-dependent maturation cleavage in provirions of a small icosahedral insect ribovirus. J Virol (1988) 2.60
Kinetics of synthesis and cleavage of encephalomyocarditis virus-specific proteins. Virology (1972) 2.54
Maturation cleavage required for infectivity of a nodavirus. J Virol (1992) 2.50
Fungal infections in patients with acute leukemia. Am J Med (1982) 2.43
Infection of mouse fibroblasts by cardioviruses: premature uncoating and its prevention by elevated pH and magnesium chloride. Virology (1971) 2.39
Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J Virol (1993) 2.39
Protein processing map of poliovirus. J Virol (1984) 2.33
Gene order of encephalomyocarditis virus as determined by studies with pactamycin. J Virol (1972) 2.26
Thermal response of rat fibroblasts stably transfected with the human 70-kDa heat shock protein-encoding gene. Proc Natl Acad Sci U S A (1991) 2.26
Colonic necrosis with Kayexalate-sorbitol enemas after renal transplantation. Ann Intern Med (1989) 2.24
Structure of an insect virus at 3.0 A resolution. Proteins (1987) 2.23
Plaque assay for black beetle virus. J Virol (1984) 2.12
An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface. J Cell Biol (1996) 2.06
Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proc Natl Acad Sci U S A (1986) 2.00
Black beetle virus: messenger for protein B is a subgenomic viral RNA. J Virol (1982) 1.96
Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest (1998) 1.93
Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J Virol (1989) 1.92
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol (1980) 1.91
Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. J Virol (1993) 1.90
Use of recombinant baculoviruses in synthesis of morphologically distinct viruslike particles of flock house virus, a nodavirus. J Virol (1993) 1.90
A precision measurement of the mass of the top quark. Nature (2004) 1.87
Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene. Mol Cell Biol (1985) 1.84
The structure of human rhinovirus 16. Structure (1993) 1.83
The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle. Structure (1997) 1.82
Relationship between sonographic and pathologic findings in epidermal inclusion cysts. J Clin Ultrasound (2001) 1.77
Capsid assembly in a family of animal viruses primes an autoproteolytic maturation that depends on a single aspartic acid residue. J Biol Chem (1994) 1.77
Picornaviral VPg sequences are contained in the replicase precursor. J Virol (1980) 1.77
Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group. Virus Genes (1995) 1.74
Complete replication of an animal virus and maintenance of expression vectors derived from it in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1996) 1.72
Proteins associated with the poliovirus RNA replication complex. Virology (1971) 1.68
Exposure and immunity to hepatitis-B virus in a liver unit. Lancet (1974) 1.68
Early and late functions in a bipartite RNA virus: evidence for translational control by competition between viral mRNAs. J Virol (1984) 1.68
WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present. J Virol (1993) 1.66
Regulation of acetyl-CoA carboxylase. Biochem Soc Trans (2006) 1.64
Neonatal tolerance induced by antibody against antigen-specific receptor. Science (1974) 1.61
Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology (1999) 1.59
Heat shock protein hsp70 protects cells from thermal stress even after deletion of its ATP-binding domain. Proc Natl Acad Sci U S A (1992) 1.54
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Radiolabeling of proteins and viruses in vitro by acetylation with radioactive acetic anhydride. J Biol Chem (1975) 1.49
Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology (2001) 1.49
An automatic high-precision acrylamide gel fractionator. Anal Biochem (1972) 1.49
Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity (1998) 1.49
Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions. J Virol (1994) 1.48
Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis. Br Med J (1975) 1.47
Measurement of the W boson mass with the D0 detector. Phys Rev Lett (2012) 1.46
Transforming growth factor-beta3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11. Endocrinology (2001) 1.45
Fragments generated by pH dissociation of ME-virus and their relation to the structure of the virion. J Mol Biol (1971) 1.44
Evidence of ambiguous processing and selective degradation in the noncapsid proteins of rhinovirus 1A. J Virol (1976) 1.43
Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann Intern Med (2000) 1.43
Flock house virus: down-regulation of subgenomic RNA3 synthesis does not involve coat protein and is targeted to synthesis of its positive strand. J Virol (1993) 1.41
Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments. J Virol (1989) 1.41
The structure of mouse-Elberfeld virus: a model. Proc Natl Acad Sci U S A (1969) 1.40
Migration of three endoclips following laparoscopic cholecystectomy. J R Coll Surg Edinb (1999) 1.38
Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol Cell Biol (1990) 1.38
Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol (1996) 1.37
Idiopathic thrombocytopenic purpura during interferon-alpha 2B treatment for chronic hepatitis. Am J Gastroenterol (1994) 1.37
Novel p19-related protein in Rous-associated virus type 61: implications for avian gag gene order. J Virol (1980) 1.37
Crystallization of a common cold virus, human rhinovirus 14: "isomorphism" with poliovirus crystals. Proc Natl Acad Sci U S A (1983) 1.36
Picornaviridae. Intervirology (1974) 1.36
Acute hepatic failure: a Western perspective. J Gastroenterol Hepatol (2000) 1.32
A 22-amino acid synthetic peptide corresponding to the second extracellular loop of rat occludin perturbs the blood-testis barrier and disrupts spermatogenesis reversibly in vivo. Biol Reprod (2001) 1.31
Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses. Intervirology (1986) 1.30
WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14. J Virol (1993) 1.30
Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity. J Biol Chem (1999) 1.29
Properties of poliovirus propagated in medium containing cesium chloride: implications for picornaviral structure. Virology (1978) 1.28
Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B. Br Med J (1976) 1.28
Preparative zone electrophoresis of proteins on polyacrylamide gels in 8 M urea. Anal Biochem (1965) 1.26
Acid-induced structural changes in human rhinovirus 14: possible role in uncoating. Proc Natl Acad Sci U S A (1992) 1.25
Poor performance of hepatitis C antibody tests in hospital patients in Uganda. J Med Virol (2010) 1.25